Adaptimmune Therapeutics PLC (ADAP)
1.135
-0.06
(-4.62%)
USD |
NASDAQ |
May 06, 16:00
1.135
0.00 (0.00%)
After-Hours: 19:50
Adaptimmune Therapeutics Shares Outstanding: 246.83M for March 4, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 04, 2024 | 246.83M |
December 31, 2023 | 227.17M |
November 07, 2023 | 227.12M |
September 30, 2023 | 226.93M |
August 07, 2023 | 226.17M |
June 30, 2023 | 225.30M |
June 01, 2023 | 225.05M |
May 10, 2023 | 165.70M |
April 18, 2023 | 165.70M |
April 17, 2023 | 165.70M |
April 11, 2023 | 165.70M |
April 03, 2023 | 165.62M |
March 31, 2023 | 165.62M |
March 28, 2023 | 165.62M |
March 03, 2023 | 165.31M |
March 01, 2023 | 165.31M |
December 31, 2022 | 164.52M |
November 07, 2022 | 163.83M |
September 30, 2022 | 163.79M |
August 02, 2022 | 163.37M |
June 30, 2022 | 162.79M |
May 23, 2022 | 162.02M |
May 06, 2022 | 161.87M |
April 21, 2022 | 156.87M |
April 07, 2022 | 156.87M |
Date | Value |
---|---|
March 31, 2022 | 156.81M |
March 11, 2022 | 156.73M |
December 31, 2021 | 156.26M |
November 02, 2021 | 156.20M |
September 30, 2021 | 156.18M |
August 06, 2021 | 156.09M |
June 30, 2021 | 156.04M |
May 12, 2021 | 155.50M |
May 04, 2021 | 155.50M |
April 08, 2021 | 155.48M |
March 31, 2021 | 155.47M |
February 24, 2021 | 155.14M |
December 31, 2020 | 154.79M |
November 04, 2020 | 154.78M |
September 30, 2020 | 154.75M |
June 30, 2020 | 154.61M |
June 04, 2020 | 153.68M |
May 29, 2020 | 130.11M |
May 27, 2020 | 130.11M |
May 13, 2020 | 130.10M |
April 22, 2020 | 130.10M |
March 31, 2020 | 130.09M |
February 26, 2020 | 130.08M |
February 07, 2020 | 129.51M |
January 24, 2020 | 126.36M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
105.11M
Minimum
Jun 30 2019
246.83M
Maximum
Mar 04 2024
158.26M
Average
156.23M
Median
Shares Outstanding Benchmarks
Biodexa Pharmaceuticals Plc | 4.385M |
NuCana PLC | 2.114M |
Autolus Therapeutics PLC | 265.93M |
TC BioPharm (Holdings) PLC | 3.195M |
Bicycle Therapeutics PLC | 37.88M |